Steven M Paul insider trades
Open-market stock purchases and sales by Steven M Paul, Unknown at Rapport Therapeutics, Inc, from SEC Form 4 filings since Jan 7, 2010.
Track record: 25% of 4 scored buys are up 5% or more since purchase, averaging -1%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Oct 22, 2026 | RAPP Rapport Therapeutics, Inc | Bought | $974K |
| Jun 10, 2026 | RAPP Rapport Therapeutics, Inc | Bought (not open market) | — |
| May 4, 2026 | SPTX Seaport Therapeutics, Inc | Bought (not open market) | — |
| May 4, 2026 | SPTX Seaport Therapeutics, Inc | Bought (not open market) | — |
| Apr 30, 2026 | SPTX Seaport Therapeutics, Inc | Bought (not open market) | — |
| Apr 30, 2026 | SPTX Seaport Therapeutics, Inc | Bought (not open market) | — |
Companies traded
- RAPP Rapport Therapeutics, Inc: 3 buys, last Oct 22, 2026
- SPTX Seaport Therapeutics, Inc: other filings, last May 4, 2026
- KRTX Karuna Therapeutics, Inc: 4 buys, 1 sale, last Mar 18, 2024
- SAGE Sage Therapeutics, Inc: 1 buy, 17 sales, last Jan 3, 2024
- ALNY Alnylam Pharmaceuticals, Inc: 1 buy, 12 sales, last Apr 1, 2022
- VYGR Voyager Therapeutics, Inc: 1 buy, last Jun 3, 2021
- SIAL Sigma Aldrich Corp: other filings, last Nov 18, 2015
- BFAM Sage Therapeutics, Inc: 1 sale, last May 1, 2015
- LLY Lilly ELI & Co: other filings, last Feb 1, 2010